ArticleObesity surgery2026
A Comparative Analysis of Postoperative Complications and Five-Year Metabolic Outcomes Following Metabolic and Bariatric Surgery in Patients with BMI 50-60 kg/m
Article in Obesity surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundA topic of debate revolves around performing metabolic and bariatric surgery (MBS) in patients with a BMI greater than 50 and 60 Kg/m MATERIALS AND
methodsThis cohort study utilized prospectively registered data from the Iran National Obesity Surgery Database (INOSD). Patients aged ≥ 18 years with a body mass index (BMI) ≥ 50 kg/m² who underwent their first metabolic and bariatric surgery (MBS) between March 2016 and January 2023 at a tertiary academic hospital were included, provided they had at least one year of follow-up. Pregnant women post-MBS were excluded. The dataset encompassed demographic information, preoperative clinical assessments, surgical details, complications, and follow-up evaluations at predefined intervals. Study outcomes adhered to international standards, defining suboptimal initial response (SoIR) as %TWL < 20% at two years post-MBS and recurrent weight gain (RWG) as weight regain > 30% of the initial weight loss. Obesity-related condition remission and improvement were assessed per ASMBS criteria. Statistical analyses were conducted using STATA 17 and R 4.3.1. Statistical significance was set at P < 0.05 with 95% confidence intervals.
resultshis study included 1,430 patients with a BMI ≥ 50 kg/m², of whom 13.1% had a BMI ≥ 60 kg/m². The BMI ≥ 60 kg/m² group had a higher proportion of males (39% vs. 29%), younger patients (median age 38 vs. 39 years), and higher prevalence of sleep apnea (32% vs. 22%). The most common procedure was One Anastomosis Gastric Bypass (69%). While ICU admission and 30-day mortality rates were higher in the BMI ≥ 60 kg/m² group, readmission rates and complications were similar between groups. At two years, the BMI ≥ 60 kg/m² group had a lower median %TWL (37% vs. 41%, p < 0.001), but SoIR and RWG rates were comparable. OAGB achieved the highest %TWL and remission of diabetes and dyslipidemia, while RYGB was most effective for hypertension remission. After the first year, weight loss outcomes favored the BMI ≥ 60 kg/m² group.
conclusionsIn conclusion, no statistically significant differences in readmission or complication rates were observed between patients with a BMI of 50-60 kg/m² and those with a BMI >60 kg/m² undergoing MBS. Over a five-year follow-up period, both groups demonstrated similar BMI reduction patterns and similar improvements or remission of obesity-related comorbidities. Among the surgical procedures analyzed, OAGB achieved the highest remission rates for T2DM and dyslipidemia and the greatest TWL% at two years, compared to RYGB and SG.
Indexed as
Identifiers
41617924What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.